| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Solid Biosciences Inc. | President and CEO, Director | Restricted Stock Units | 120K | $960K | $7.99 | Feb 13, 2024 | Direct |
| Solid Biosciences Inc. | President and CEO, Director | Common Stock | 17.4K | $96.4K | $5.53 | Dec 4, 2023 | Direct |
| Solid Biosciences Inc. | President and CEO, Director | Employee Stock Option (Right to Buy) | 240K | Feb 13, 2024 | Direct | ||
| Verve Therapeutics, Inc. | Director | Stock Option (right to buy) | 136K | Jun 26, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VERV | Verve Therapeutics, Inc. | Jun 26, 2024 | 1 | $0 | 4 | Jun 28, 2024 | Director |
| SLDB | Solid Biosciences Inc. | Feb 13, 2024 | 2 | $0 | 4 | Feb 16, 2024 | President and CEO, Director |
| SLDB | Solid Biosciences Inc. | Dec 2, 2023 | 3 | -$32.5K | 4 | Dec 5, 2023 | President and CEO, Director |
| VERV | Verve Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| SLDB | Solid Biosciences Inc. | Dec 2, 2022 | 3 | $0 | 4 | Dec 5, 2022 | President and CEO, Director |
| SLDB | Solid Biosciences Inc. | Dec 2, 2022 | 0 | $0 | 3 | Dec 5, 2022 | President and CEO, Director |
| VERV | Verve Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| VERV | Verve Therapeutics, Inc. | Jun 9, 2022 | 0 | $0 | 3 | Jun 13, 2022 | Director |